Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway

[1]  Y. Ouchi,et al.  Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women , 2009, Journal of Bone and Mineral Metabolism.

[2]  Yin-kun Liu,et al.  Gene expression analysis of major lineage‐defining factors in human bone marrow cells: Effect of aging, gender, and age‐related disorders , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[3]  M. Manigrasso,et al.  Comparison of Fracture Healing Among Different Inbred Mouse Strains , 2008, Calcified Tissue International.

[4]  T. Kawecki,et al.  Heterozygosity of SNP513 in intron 9 of the human calretinin gene (CALB2) is a risk factor for colon cancer. , 2007, Anticancer research.

[5]  C. Perou,et al.  Common Genetic Variation in GATA-Binding Protein 3 and Differential Susceptibility to Breast Cancer by Estrogen Receptor α Tumor Status , 2007, Cancer Epidemiology Biomarkers & Prevention.

[6]  S. Mundlos,et al.  A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. , 2007, American journal of human genetics.

[7]  Steven M. Tommasini,et al.  Genetic randomization reveals functional relationships among morphologic and tissue-quality traits that contribute to bone strength and fragility , 2007, Mammalian Genome.

[8]  E. Hunziker,et al.  Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of different types of cartilaginous tissue. , 2007, Arthritis and rheumatism.

[9]  S. Kakar,et al.  Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells. , 2007, Bone.

[10]  E. Canalis,et al.  Bone morphogenetic proteins and their antagonists , 2007, Reviews in Endocrine and Metabolic Disorders.

[11]  C. Tabin,et al.  BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing , 2006, Nature Genetics.

[12]  S. Akbarian,et al.  Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders , 2006, Brain Research Reviews.

[13]  P. Giannoudis,et al.  The role of inhibitory molecules in fracture healing. , 2006, Injury.

[14]  David J Balding,et al.  Logistic regression protects against population structure in genetic association studies. , 2005, Genome research.

[15]  Eleftherios Tsiridis,et al.  Current concepts of molecular aspects of bone healing. , 2005, Injury.

[16]  K. Miyazono,et al.  Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia , 2004, The Journal of cell biology.

[17]  M. Zaidi,et al.  Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. , 2003, The Journal of clinical investigation.

[18]  A. Economides,et al.  Skeletal overexpression of noggin results in osteopenia and reduced bone formation. , 2003, Endocrinology.

[19]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[20]  E. Eriksen,et al.  Maintenance of Osteoblastic and Adipocytic Differentiation Potential with Age and Osteoporosis in Human Marrow Stromal Cell Cultures , 2002, Calcified Tissue International.

[21]  E. Lonn,et al.  The T-786→C Mutation in Endothelial Nitric Oxide Synthase Is Associated With Hypertension , 2002, Hypertension.

[22]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[23]  Gerald R. Williams,et al.  Complications of Thermal Capsulorrhaphy of the Shoulder , 2001, The Journal of bone and joint surgery. American volume.

[24]  M. Bamshad,et al.  Identical mutations in NOG can cause either tarsal/carpal coalition syndrome or proximal symphalangism , 2001, Genetics in Medicine.

[25]  C. Daviaud,et al.  Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. , 2001, American journal of medical genetics.

[26]  K. Takaoka,et al.  Colocalization of Noggin and Bone Morphogenetic Protein‐4 During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  G. Zych,et al.  Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.

[28]  P. Aspenberg,et al.  The Bone Morphogenetic Proteins Antagonist Noggin Inhibits Membranous Ossification , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  D. Macdonald,et al.  Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. , 2000, The Journal of bone and joint surgery. British volume.

[30]  D. Altman,et al.  Statistics Notes: The odds ratio , 2000 .

[31]  R. Jilka,et al.  Essential Requirement of BMPs‐2/4 for Both Osteoblast and Osteoclast Formation in Murine Bone Marrow Cultures from Adult Mice: Antagonism by Noggin , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  K. Miyazono.  Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. , 1999, Bone.

[33]  A. McMahon,et al.  Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. , 1998, Science.

[34]  N. Jena,et al.  BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. , 1997, Experimental cell research.

[35]  K. Miyazono,et al.  Bone morphogenetic protein receptors. , 1996, Bone.

[36]  A. Bradley,et al.  Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. , 1996, Development.

[37]  A. Bradley,et al.  BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. , 1995, Genes & development.

[38]  S. Anttila,et al.  Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review. , 1995, Gene.

[39]  S. Furner,et al.  Musculoskeletal Conditions in the United States , 1992 .

[40]  W. Risser.  Musculoskeletal Injuries , 1990, Clinical pediatrics.

[41]  C. A. Rockwood,et al.  THE AMERICAN Academy of Orthopaedic Surgeons. , 1988, The Journal of bone and joint surgery. American volume.

[42]  Yusuke Nakamura,et al.  DNA variations in human and medical genetics: 25 years of my experience , 2009, Journal of Human Genetics.

[43]  C. Perou,et al.  Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  In Ho Choi,et al.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva , 2006, Nature Genetics.

[45]  N. Tejwani,et al.  Evolving trends in the care of polytrauma patients. , 2006, Injury.

[46]  S. Ortolani,et al.  Genetics of osteoporosis , 1994, Calcified Tissue International.

[47]  C. Clevenger.  Signal transduction. , 2003, Breast disease.

[48]  B. Browner,et al.  Skeletal trauma: basic science, Management and reconstruction , 2003 .